Applied Therapeutics appoints Catherine Thorpe as interim CFO and CAO; Steven Ortega resigns

Applied Therapeutics, Inc.

Steven Ortega resigns as Chief Accounting Officer and Interim Principal Financial Officer effective June 30, 2023, to pursue another opportunity.
Catherine Thorpe appointed interim Principal Financial Officer and Chief Accounting Officer effective June 16, 2023.
Thorpe is a CFGI employee; Company entered an engagement letter with CFGI for financial, accounting, and tax services.
Company to pay CFGI hourly rate for Thorpe's services; fees expected similar to Ortega's compensation.
No familial relationships with executives; Thorpe to enter standard indemnification agreement.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed (interim)

Steven Ortega

Chief Accounting Officer and Interim Principal Financial Officer

Applied Therapeutics, Inc.

Effective: 2023-06-30
Successor: Catherine Thorpe
Filed: June 16, 2023, 7:59 PM ET

On June 14, 2023, Steven Ortega notified Applied Therapeutics, Inc. (the “Company”) that he will resign from his position as the Company’s Chief Accounting Officer and Interim Principal Financial Officer effective as of June 30, 2023, to pursue another professional opportunity.

Appointed (interim)

Catherine Thorpe

Interim Principal Financial Officer and Chief Accounting Officer

Applied Therapeutics, Inc.

Effective: 2023-06-16
Filed: June 16, 2023, 7:59 PM ET

On June 16, 2023, the Company appointed Catherine Thorpe as the interim Principal Financial Officer and Chief Accounting Officer, effective immediately, in light of Mr. Ortega’s anticipated departure and Mr. Ortega ceased to serve in such roles.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Steven Ortega resigned as Chief Accounting Officer and Interim Principal Financial Officer at Applied Therapeutics, Inc..

Action: resigned
Role: Chief Accounting Officer and Interim Principal Financial Officer

Exact text from the filing

On June 14, 2023, Steven Ortega notified Applied Therapeutics, Inc. (the “Company”) that he will resign from his position as the Company’s Chief Accounting Officer and Interim Principal Financial Officer effective as of June 30, 2023, to pursue another professional opportunity.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Catherine Thorpe was appointed as Interim Principal Financial Officer and Chief Accounting Officer at Applied Therapeutics, Inc..

Action: appointed
Role: Interim Principal Financial Officer and Chief Accounting Officer

Exact text from the filing

On June 16, 2023, the Company appointed Catherine Thorpe as the interim Principal Financial Officer and Chief Accounting Officer, effective immediately, in light of Mr. Ortega’s anticipated departure and Mr. Ortega ceased to serve in such roles.

View on SEC.gov

Source: SEC EDGAR

accession 0001104659-23-072300

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.